Jove
Visualize
联系我们

相关概念视频

Clinical Trials: Overview01:11

Clinical Trials: Overview

4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
Preclinical Development: Overview01:28

Preclinical Development: Overview

5.7K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.7K
Drug Discovery: Overview01:26

Drug Discovery: Overview

10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

1.1K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.1K
Clinical Trials01:16

Clinical Trials

10.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.1K
Biopharmaceutical Factors Influencing Drug Product Design: Overview01:22

Biopharmaceutical Factors Influencing Drug Product Design: Overview

217
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
217

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

[Frontiers in biomedical research].

Zhonghua yi xue za zhi·2023
Same author

[Immunological research of COVID-19 and emerging infectious diseases].

Zhonghua yi xue za zhi·2021
Same author

[Considerations and recommendations on the independent innovation development of medical science and technology].

Zhonghua yi xue za zhi·2020
Same author

First Report of Trichoderma oblongisporum Causing Green Mold Disease on Lentinula edodes (shiitake) in China.

Plant disease·2019
Same author

[Emphasis on immunological research and its application in disease control from national perspective].

Zhonghua yi xue za zhi·2019
Same author

[Inheriting the excellence to innovate medical research in China].

Zhonghua yi xue za zhi·2018
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关实验视频

Updated: Jan 7, 2026

Development of New Therapeutic Applications Using Microfluidics
08:56

Development of New Therapeutic Applications Using Microfluidics

Published on: October 1, 2007

5.7K

[以创新驱动的制药发展和临床进步]

X T Cao1

  • 1Center for Immunotherapy, Chinese Academy of Medical Sciences, Beijing 100005, China.

Zhonghua yi xue za zhi
|December 25, 2025
PubMed
概括

中国中国中国中国.

科学领域:

  • 制药发展 制药发展
  • 生物医学技术 生物医学技术
  • 临床进步的临床进展

背景情况:

  • 中国在创新药物开发和许可协议方面取得了全球领先地位.
  • 这一进步归因于生物医学技术创新,政策支持,加快监管流程和支付系统改革.

研究的目的:

  • 系统地分析中国创新药物开发的进展,挑战和未来方向.
  • 要突出关键的挑战,当前的热点,以及药物开发中的潜在突破.
  • 概述将制药发展与医疗实践相结合的优先方向.

主要方法:

  • 对中国创新药物开发格局的系统分析.
  • 审查当前的挑战,包括最初的创新能力和临床调整.
  • 审查政策倡议和未来的战略方向.

主要成果:

  • 在创新药物开发和许可协议方面,中国在全球排名第一.
  • 持续面临的挑战包括最初创新能力较弱,临床需求不一致以及国际参与有限.
  • 一个新的国家项目侧重于能力建设,原创创新和协作生态系统.

结论:

  • 中国的目标是到2035年建立一个世界领先的,独立的药物创新系统.

更多相关视频

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

14.3K
Ole Isacson: Development of New Therapies for Parkinson's Disease
23:53

Ole Isacson: Development of New Therapies for Parkinson's Disease

Published on: April 29, 2007

8.3K

相关实验视频

Last Updated: Jan 7, 2026

Development of New Therapeutic Applications Using Microfluidics
08:56

Development of New Therapeutic Applications Using Microfluidics

Published on: October 1, 2007

5.7K
Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

14.3K
Ole Isacson: Development of New Therapies for Parkinson's Disease
23:53

Ole Isacson: Development of New Therapies for Parkinson's Disease

Published on: April 29, 2007

8.3K
  • 应对当前的挑战对于持续增长和支持"健康中国"倡议至关重要.
  • 促进药物开发和临床实践之间的更深层次的整合是关键优先事项.